CAMBRIDGE NUTRITIONAL SCIENCES PLC | RNS Reach Story | ||
| Go to market news section | ||
|
Omega Diagnostics Group PLC
('Omega' or 'the Company' or the 'Group')
Investor results briefing
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces it will be hosting an investor evening for all investors on Wednesday 4 December 2019, accompanying the interim results for six months ended 30 September 2019.The event will take place in the No.1 Cornhill, London, EC3V 3ND at 4.30pm for a 4.45pm start. This will be followed by light refreshments, and a chance to network.
The results presentation will be available on the Company website shortly after the event. No new information will be disclosed.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or emailomega@walbrookpr.com.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Bill Rhodes, Interim Non-Executive Chairman | www.omegadiagnostics.com |
Colin King, Chief Executive | |
Kieron Harbinson, Group Finance Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/James Thompson/Hannah Boros (Corporate Finance) | |
Camille Gochez (ECM) | |
Walbrook PR Limited | Tel: 020 7933 8780 oromega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
| London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply. |
| ©2014London Stock Exchange plc. All rights reserved |
Investor results briefing - RNS
Attachments
- Original document
- Permalink
Disclaimer
Omega Diagnostics Group plc published this content on 21 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 November 2019 07:05:06 UTC
